US net sales, recognized by Viatris, reached an all-time high of $66.7 million in Q4 2024 and $238.6 million in FY 2024, up 10% and 8%, respectively ...

Patent strengthens CVC's leading position in European CRISPR IP landscape, providing security to over 150 ERS Genomics licensees. DUBLIN and CHESTER, England, Feb. 26, 2025 /PRNew ...

The list extends into the pharma industry, including Pfizer, GSK, and Novo Nordisk. On 14 November, Eli Lilly became a part of this group, after an account using its name and logo sent out a Tweet ...

Clinical Trials Begin This Month, New Vaccine Targeted for 2021 Medicago and GSK plan to begin a Phase 1 clinical trial ... Flourish enters the Bay Area market with the deal. Flourish Research logo ...

NEW YORK CITY, NY / ACCESS Newswire / March 15, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds ...

NEW YORK, NY / ACCESS Newswire / March 15, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

The U.S. Food and Drug Administration approved British drugmaker GSK's (GSK.L), opens new tab combination vaccine to protect against meningococcal infection for use in people aged 10 through 25 ...

GSK Stock Performance GSK opened at $40.08 on Friday. The firm has a market cap of $83.07 billion, a P/E ratio of 25.21, a price-to-earnings-growth ratio of 1.12 and a beta of 0.58. GSK plc has a ...

Additionally, GSK’s new 5-in-1 meningitis vaccine, Penmenvy, received approval from the US FDA, offering protection against five common serogroups of Neisseria meningitidis for individuals aged ...

NEW YORK, March 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE: GSK). Shareholders who purchased shares of GSK during the class period ...